04:35 PM EDT, 05/16/2024 (MT Newswires) -- Peter S Kim, Director, on May 14, 2024, executed a purchase for 25,000 shares in Entrada Therapeutics ( TRDA ) for $364,673. Following the Form 4 filing with the SEC, Kim has control over a total of 92,412 shares of the company, with 92,412 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1689375/000168937524000029/xslF345X03/wk-form4_1715891608.xml

Price: 15.04, Change: +0.09, Percent Change: +0.60